Small-Cap Biotech Surges Almost 350% on Cancer-Drug Trial Data

(Bloomberg) -- Small-cap drug developer Five Prime Therapeutics Inc. is on track to post one of this year’s biggest daily stock moves after reporting promising data from a mid-stage cancer study.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.